RecruitingNot ApplicableNCT07033091

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Sponsor

The Institute of Molecular and Translational Medicine, Czech Republic

Enrollment

20,000 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Oropharynx Cancer

Summary

This study defines the prevalence of oral infection with high-risk human papillomaviruses (hrHPV) in individuals over 40 years of age in the Czech Republic. It also establishes an effective methodology for oropharyngeal carcinoma screening and optimization of screening and testing procedures.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying how common the HPV (human papillomavirus) infection is in healthy adults aged 40 and over, and whether a simple mouth-rinse test could be used to screen for throat and mouth cancers caused by HPV. You may be eligible if: you are 40 years or older; you can gargle and rinse your mouth independently; and you have signed the informed consent form. You may NOT be eligible if: you have previously been diagnosed with a head or neck cancer. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSelf-sampling by gargling kit at dental clinic

Participants will perform a self-sampling at the dental clinic using gargling kit

OTHERQuestionnaire

Participants will answer questionnaire online/paper at their home or at the dental clinic

DIAGNOSTIC_TESTSelf-sampling by gargling kit at home

Participants will perform a self-sampling at home using gargling kit

DIAGNOSTIC_TESTBlood sampling

Venous blood will be collected from study participants with oral hrHPV positivity, in which the presence of circulating hrHPV DNA will be determined.

DIAGNOSTIC_TESTSelf-sampling of the urogenital area

In case of a positive examination in the oropharynx, the tested individuals will be offered a self-collection HPV examination in the urogenital area (cervicovaginal swab in women or external genital swab in men).